Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
05/2012
05/02/2012CN102429947A Freckle-removing liquid as well as preparation method and application thereof
05/02/2012CN102429943A Sugar-free erigeron breviscapus mixture and preparation method thereof
05/02/2012CN102429935A Brucea fruit oil self-emulsifying preparation and preparation method thereof
05/02/2012CN102429934A Nanometer ginkgo leaf extract external preparation and application thereof
05/02/2012CN102429931A Compound fermented cordyceps fungus powder salvianic acid combined drug
05/02/2012CN102429913A Compound clobetasol propionate liposome and preparation thereof
05/02/2012CN102429912A Pharmaceutical composition prepared with micronized prasterone or sodium prasterone sulfate and use thereof
05/02/2012CN102429911A Application of ZSTK474 to preparation of medicine for treating autoimmune diseases
05/02/2012CN102429908A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
05/02/2012CN102429902A Pharmaceutical composition of alanyl glutamine and compound amino acid
05/02/2012CN102429894A Application of fluoxetine to treatment of depigmentation disease
05/02/2012CN102429859A Preparation method of diphenhydramine cream
05/02/2012CN102429844A Biological environment-friendly antioxidant itching-relieving bath wash and preparation method thereof
05/02/2012CN102429843A Biological environment-friendly dandruff-removing and itch-relieving liquid shampoo and preparation method thereof
05/02/2012CN102429839A Method for preparing facial mask soaking liquid
05/02/2012CN102429406A Traditional Chinese medicine health care sole
05/02/2012CN101926850B Natural plant anti-dandruff spray and preparation method thereof
05/02/2012CN101892177B Antifungal lipopeptid-containing skin liniment and preparation method thereof
05/02/2012CN101822779B Antipyretic powder containing honeysuckle and indigowoad leaf and preparation method thereof
05/02/2012CN101785832B Traditional Chinese medicine preparation and preparation method thereof for skin disease treatment
05/02/2012CN101700243B Novel medicine carrying woundplast with treating function
05/02/2012CN101675969B A traditional Chinese medicinal ointment for treating allergic dermatitis
05/02/2012CN101574465B Special acne removal traditional Chinese medicine tincture for ladies
05/02/2012CN101564499B Acne dispelling Chinese medicament tincture special for men
05/02/2012CN101519439B Freezeproof polypeptide, synthesis, composition containing same and application thereof
05/02/2012CN101485675B Adapalene and hydrochloric clindamycin compound gel preparation and preparation method thereof
05/01/2012US8168803 Methods of using [3.2.0] heterocyclic compounds and analogs thereof
05/01/2012US8168214 Local administration of gallium compositions to treat pain
05/01/2012US8168189 Protein A compositions and methods of use
05/01/2012CA2719512A1 Polymeric topical compositions
05/01/2012CA2455633C Sustained-release therapeutic bioadhesive systems
05/01/2012CA2439408C Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor
05/01/2012CA2437579C Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
05/01/2012CA2404212C A process for the preparation of epothilone analogs and intermediates
05/01/2012CA2333466C Gbs toxin receptor
04/2012
04/26/2012WO2012054862A2 Agents, compositions, and methods for treating pruritis and related skin conditions
04/26/2012WO2012054447A2 Use of storage stable viscous phospholipid depot to treat wounds
04/26/2012WO2012053976A1 Use of exosomes to promote or enhance hair growth
04/26/2012WO2012053014A2 Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
04/26/2012WO2012053013A2 Pharmaceutical compositions of anti-acne agents
04/26/2012WO2012053010A2 Method for treatment of acne using pharmaceutical compositions of clindamycin
04/26/2012WO2012053007A1 Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
04/26/2012WO2012052956A1 Methods and compositions for treating pox virus infections with an 1, 4 -naphthoquinone as active agent
04/26/2012WO2012052753A1 Quinazolin-4 (3h) -one derivatives used as pi3 kinase inhibitors
04/26/2012WO2012052563A1 Compositions comprising a filler product and a compound of the tetracycline family used at a subantimicrobial dose
04/26/2012WO2012052562A1 Compositions comprising a filler product and a chemically modified tetracycline
04/26/2012WO2012052479A2 Brimonidine gel compositions and methods of use
04/26/2012WO2012052395A1 Isoxazole derivatives used as oestrogen modulators
04/26/2012WO2012052180A1 Combinations comprising dhodh inhibitors and cox inhibitors
04/26/2012WO2012052179A1 Amino derivatives for the treatment of proliferative skin disorders
04/26/2012WO2012051745A1 A method of extracting bioactive substances by breaking wall of chlorella pyrenoidosa
04/26/2012WO2012021165A9 Methods and compositions for treating disorders associated with hyperactive immune system
04/26/2012WO2012015789A3 Composition and method for the topicaltreatment of dermatitis
04/26/2012US20120101427 Novel photosensitizer formulations for oral administration
04/26/2012US20120101161 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
04/26/2012US20120101156 COMPOSITIONS COMPRISING A RETINOID AND AN NFkB-INHIBITOR AND THEIR METHODS OF USE
04/26/2012US20120101155 Zinc Salt Compositions for the Prevention of Dermal and Mucosal Irritation
04/26/2012US20120101144 Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
04/26/2012US20120101141 Gel compositions and methods of use
04/26/2012US20120101136 5-membered heteroaryl derivatives used as sphingosine 1- phosphate receptor agonists
04/26/2012US20120101134 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
04/26/2012US20120101124 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
04/26/2012US20120101123 Compounds
04/26/2012US20120101120 Pure isomers of tritoqualine
04/26/2012US20120101112 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/26/2012US20120101104 Topical gel compositions and methods of use
04/26/2012US20120101083 S1p1 agonists comprising a bicyclic n-containing ring
04/26/2012US20120101059 Sulphated hyaluronic acids as regulator agents of the cytokine activity
04/26/2012US20120101052 15-thia steroid compounds and compositions
04/26/2012US20120101038 Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes
04/26/2012US20120101036 Novel cellular factor-containing solution compositions
04/26/2012US20120101028 Anti-inflammatory compounds and uses thereof
04/26/2012US20120101026 Compounds For Enzyme Inhibition
04/26/2012US20120101025 Compounds For Enzyme Inhibition
04/26/2012US20120100235 Papaya puree and uses thereof
04/26/2012US20120100222 Skin function-improving composition
04/26/2012US20120100183 Topical base and active agent-containing compositions, and methods for improving and treating skin
04/26/2012US20120100178 Compositions And Methods For Treatment Of Microbial Infections
04/26/2012US20120100161 Amatoxin-Armed Therapeutic Cell Surface Binding Components Designed for Tumour Therapy
04/26/2012US20120100139 CD86 Antagonist Multi-Target Binding Proteins
04/26/2012US20120100107 In vivo transfer methods for wound healing
04/26/2012US20120100106 Collagen-binding synthetic peptidoglycans for wound healing
04/26/2012US20120100103 In situ forming hydrogel and biomedical use thereof
04/26/2012US20120100081 Composition and Method for Treating Wounds
04/26/2012US20120100074 Humanized antibodies against light and uses thereof
04/26/2012CA2815299A1 Compositions comprising a filler product and a compound of the tetracycline family used at a subantimicrobial dose
04/26/2012CA2814952A1 Brimonidine gel compositions and methods of use
04/26/2012CA2814577A1 Use of storage stable viscous phospholipid depot to treat wounds
04/26/2012CA2814378A1 Antimicrobial polyether and polyol compounds
04/26/2012CA2812187A1 Topical base and active agent-containing compositions, and methods for improving and treating skin
04/26/2012CA2811171A1 Quinazolin-4 (3h) -one derivatives used as pi3 kinase inhibitors
04/25/2012EP2444401A1 Novel imidazopyridine compound
04/25/2012EP2444097A1 Nfat signal inhibitor and calcineurin inhibitor
04/25/2012EP2444088A1 Amino derivatives for the treatment of proliferative skin disorders
04/25/2012EP2444086A1 Combinations comprising DHODH inhibitors and COX inhibitors
04/25/2012EP2443110A1 S1p1 agonists comprising a bicyclic n-containing ring
04/25/2012EP2443089A1 Deuterated i soindoline- i, 3-dione derivatives as pde4 and tnf-alpha inhibitors
04/25/2012EP2442813A1 A medicinal anti acne cream comprising chitosan and a process to make it
04/25/2012EP2442785A1 Agent for preventing or treating abnormality in skin water permeation function
04/25/2012EP2274419B1 Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations
1 ... 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 ... 1065